SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹1.08 Cr | ₹0.53 Cr | ₹0.58 Cr | ₹0.28 Cr | ₹0.33 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹1.08 Cr |
| Mar2025 | ₹0.53 Cr |
| Mar2024 | ₹0.58 Cr |
| Mar2020 | ₹0.28 Cr |
| Mar2019 | ₹0.33 Cr |
How is Deferred Tax Assets / Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.08 Cr | 103.77 | |
| Mar2025 | ₹0.53 Cr | -8.46 | |
| Mar2024 | ₹0.58 Cr | 110.55 | |
| Mar2020 | ₹0.28 Cr | -17.17 | |
| Mar2019 | ₹0.33 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹872.5 Cr | -5.5% | 1.1% | 28.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -5.5% |
1.1% |
28.8% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses